STOCK TITAN
  1. Home
  2. CMLTU

EQRX Stock Price, News & Analysis

CMLTU NASDAQ

Company Description

EQRX (NASDAQ: CMLTU) is a publicly traded company.

CMLTU stock has declined 20.7% over the past year.

This page provides a comprehensive overview of CMLTU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-20.73%
Performance 1 year
$0.0
Market Cap
55.2M
Shares outstanding

EQRX (CMLTU) stock. Over the past 12 months, the stock has lost 20.7%.

Latest News

View All
+0.66%

EQRx and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination

+0.07%

EQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference

conferences
-0.19%

EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in Middle East, Turkey and Africa

partnership
-0.10%

EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership

partnership
-0.19%

EQRx Launches “Remaking Medicine: On The Record” Investor Video Series

+0.19%

EQRx and NHSE Sign Memorandum of Understanding to Enter into England’s First Population Health Partnership for Cancer Drugs

partnership

EQRX has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, partnership, management, clinical trial. View all CMLTU news →

SEC Filings

View All

No SEC filings available for CMLTU.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months